Primary prophylaxis of variceal hemorrhage: A randomized controlled trial comparing band ligation, propranolol, and isosorbide mononitrate

Gastroenterology

Volumn 123, Issue 3, 2002, Pages 735-744

  Lui, Hock F ^a   Stanley, Adrian J ^a   Forrest, Ewan H ^a   Jalan, Rajiv ^a   Hislop, W Stuart ^b   Mills, Peter R ^c   Finlayson, Niall D C ^a   Macgilchrist, Alastair J ^a   Hayes, Peter C ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^b ROYAL ALEXANDRA HOSPITAL   (United Kingdom)

^c GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ISOSORBIDE MONONITRATE; PROPRANOLOL;

ADULT; AGED; ARTICLE; BANDING LIGATION; CLINICAL FEATURE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG WITHDRAWAL; DYSPNEA; ESOPHAGUS VARICES BLEEDING; FATIGUE; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; INSOMNIA; LIGATION; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; TREATMENT INDICATION; TREATMENT OUTCOME; VERTIGO;

EID: 0036731212     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2002.35385     Document Type: Article

References (34)

1. The course of patients after variceal haemorrhage
2. Portal hypertension and variceal bleeding: An AASLD single topic symposium
3. Short-term effects of propranolol on portal venous pressure
4. Enhancement of portal pressure reduction by the association of isosorbide-5-mononitrate to propranolol administration in/patients with cirrhosis
5. Pharmacological treatment of portal hypertension: An evidence-based approach
6. Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices
7. Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding
8. Endoscopic variceal ligation in prophylaxis of first variceal bleeding in cirrhotic patients with high-risk esophageal varices
9. A randomized controlled trial of endoscopic variceal band ligation for primary prophylaxis of variceal bleeding
10. Prophylactic banding ligation of high-risk esophageal varices in patients with cirrhosis: A prospective, randomized trial
11. A prospective randomized trial between the prophylactic endoscopic variceal ligation and propranolol administration for prevention of first bleeding in cirrhotic patients with high risk esophageal varices
12. Prophylactic band ligation of large esophageal varices
13. Injection sclerotherapy for esophageal varices. A prospective randomized trial of different treatment schedules
14. Prediction of first variceal haemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study
15. Recommendations for standards of sedation and patient monitoring during gastrointestinal endoscopy - British Society of Gastroenterology 1991
16. Definitions, methodology and therapeutic strategies in portal hypertension
17. Effects of isosorbide-5-mononitrate compared with propranolol on first bleeding and long-term survival in cirrhosis
18. Band ligation versus propranolol or isosorbide mononitrate in the primary prophylaxis of variceal haemorrhage: Preliminary results of a randomised controlled trial
19. Endoscopic variceal ligation for primary prophylaxis of oesophageal variceal bleed: Preliminary report of a randomized controlled trial
20. A meta-analysis of endoscopic variceal ligation for primary prophylaxis of esophageal bleeding
21. Primary prevention of bleeding from esophageal varices
22. Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding. A meta-analysis
23. A prospective, randomized trial of sclerotherapy versus ligation in the management of bleeding esophageal varices
24. Propranolol in the prevention of first upper gastrointestinal tract haemorrhage in patients with cirrhosis of the liver and oesophageal varices
25. Propranolol prevents first gastrointestinal bleeding in nonascitic cirrhotic patients. Final report of a multicenter randomized trial
26. Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials
27. Preventive therapy of first gastrointestinal bleeding in patients with cirrhosis: Results of a controlled trial comparing propranolol, endoscopic sclerotherapy and placebo
28. Prophylaxis of first haemorrhage from oesophageal varices by sclerotherapy, propranolol or both in cirrhotic patients. A randomized multicenter trial
29. Prediction of oesophageal variceal bleeding: Evaluation of the beppu and North Italian Endoscopic Club scores by an independent group
30. Prognostic value of hepatic venous pressure gradient measurements in alcoholic cirrhosis: A 10-year prospective study
31. Long-term results of a clinical trial of nadolol with or without isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis
32. Hemodynamic evaluation of the addition of isosorbide-5-mononitrate to nadolol in cirrhotic patients with insufficient response to the beta-blocker alone
33. Effect of chronic treatment with nadolol plus isosorbide mononitrate on liver blood flow and liver metabolic activity in cirrhosis